Zelira Therapeutics Ltd (ZLD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2010 | 06-2009 | 06-2008 | 06-2007 | 06-2006 | |
| Sales | 34 | N/A | N/A | 21,079 | 141 |
| Cost of Goods | N/A | N/A | N/A | -3,848 | N/A |
| Gross Profit | 34 | N/A | N/A | 24,927 | 141 |
| Operating Expenses | 1,150 | 1,855 | 488 | 46,550 | 1,407 |
| Operating Income | -1,116 | -1,855 | -488 | -21,623 | -1,266 |
| Interest Expense | N/A | 34 | N/A | 102 | 203 |
| Other Income | -572 | -18,382 | 23 | -16,437 | -16 |
| Pre-tax Income | -1,688 | -20,271 | -465 | -38,162 | -1,486 |
| Income Tax | 0 | 0 | 0 | 0 | -584 |
| Net Income Continuous | -1,688 | -20,271 | -465 | -38,162 | -901 |
| Net Income Discontinuous | N/A | N/A | 13,080 | N/A | N/A |
| Net Income | $-1,688 | $-20,271 | $12,615 | $-38,162 | $-901 |
| EPS Basic Total Ops | -5.03 | -116.53 | 464.43 | -15,464.96 | -521.38 |
| EPS Basic Continuous Ops | -5.03 | -116.53 | -16.84 | -15,464.96 | -521.38 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | 481.27 | 0.00 | N/A |
| EPS Diluted Total Ops | -5.03 | -116.53 | 464.43 | -15,464.96 | -521.38 |
| EPS Diluted Continuous Ops | -5.03 | -116.53 | -17.14 | -15,464.96 | -521.38 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 481.27 | 0.00 | N/A |
| EBITDA(a) | $-1,099 | $-20,220 | $-488 | $-34,908 | $-1,220 |